Cycle Pharmaceuticals: 3D printed orphan drugs to hit market in 2-3 years

As 3D printing continues to take the medical industry by storm, one pharmaceutical company is ready to take advantage of what it sees as an exciting new business opportunity. Cambridge-based Cycle Pharmaceuticals (Cycle Pharma) has just announced its strategy to harness 3D printing technology as a chief means of producing prescription drugs by way of a new partnership.

from 3ders.org - http://www.3ders.org